Human TNFRSF1B/CD120b/p75 ORF/cDNA clone-Adenovirus particle (BC052977)
Cat. No.: vGMAP000424
Pre-made Human TNFRSF1B/CD120b/p75 Adenovirus for TNFRSF1B overexpression in-vitro and in-vivo. The TNFRSF1B adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified TNFRSF1B-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
TNFR2/TNFRSF1B/CD120b/TNF-R2/TNFRSF1B/CD120b products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000424 | Human TNFRSF1B Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000424 |
| Gene Name | TNFRSF1B |
| Accession Number | BC052977 |
| Gene ID | 7133 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 1386 bp |
| Gene Alias | CD120b,p75,p75TNFR,TBPII,TNF-R-II,TNF-R75,TNFBR,TNFR80 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCGCCCGTCGCCGTCTGGGCCGCGCTGGCCGTCGGACTGGAGCTCTGGGCTGCGGCGCACGCCTTGCCCGCCCAGGTGGCATTTACACCCTACGCCCCGGAGCCCGGGAGCACATGCCGGCTCAGAGAATACTATGACCAGACAGCTCAGATGTGCTGCAGCAAATGCTCGCCGGGCCAACATGCAAAAGTCTTCTGTACCAAGACCTCGGACACCGTGTGTGACTCCTGTGAGGACAGCACATACACCCAGCTCTGGAACTGGGTTCCCGAGTGCTTGAGCTGTGGCTCCCGCTGTAGCTCTGACCAGGTGGAAACTCAAGCCTGCACTCGGGAACAGAACCGCATCTGCACCTGCAGGCCCGGCTGGTACTGCGCGCTGAGCAAGCAGGAGGGGTGCCGGCTGTGCGCGCCGCTGCGCAAGTGCCGCCCGGGCTTCGGCGTGGCCAGACCAGGAACTGAAACATCAGACGTGGTGTGCAAGCCCTGTGCCCCGGGGACGTTCTCCAACACGACTTCATCCACGGATATTTGCAGGCCCCACCAGATCTGTAACGTGGTGGCCATCCCTGGGAATGCAAGCATGGATGCAGTCTGCACGTCCACGTCCCCCACCCGGAGTATGGCCCCAGGGGCAGTACACTTACCCCAGCCAGTGTCCACACGATCCCAACACACGCAGCCAACTCCAGAACCCAGCACTGCTCCAAGCACCTCCTTCCTGCTCCCAATGGGCCCCAGCCCCCCAGCTGAAGGGAGCACTGGCGACTTCGCTCTTCCAGTTGGACTGATTGTGGGTGTGACAGCCTTGGGTCTACTAATAATAGGAGTGGTGAACTGTGTCATCATGACCCAGGTGAAAAAGAAGCCCTTGTGCCTGCAGAGAGAAGCCAAGGTGCCTCACTTGCCTGCCGATAAGGCCCGGGGTACACAGGGCCCCGAGCAGCAGCACCTGCTGATCACAGCGCCGAGCTCCAGCAGCAGCTCCCTGGAGAGCTCGGCCAGTGCGTTGGACAGAAGGGCGCCCACTCGGAACCAGCCACAGGCACCAGGCGTGGAGGCCAGTGGGGCCGGGGAGGCCCGGGCCAGCACCGGGAGCTCAGATTCTTCCCCTGGTGGCCATGGGACCCAGGTCAATGTCACCTGCATCGTGAACGTCTGTAGCAGCTCTGACCACAGCTCACAGTGCTCCTCCCAAGCCAGCTCCACAATGGGAGACACAGATTCCAGCCCCTCGGAGTCCCCGAAGGACGAGCAGGTCCCCTTCTCCAAGGAGGAATGTGCCTTTCGGTCACAGCTGGAGACGCCAGAGACCCTGCTGGGGAGCACCGAAGAGAAGCCCCTGCCCCTTGGAGTGCCTGATGCTGGGATGAAGCCCAGTTAA |
| ORF Protein Sequence | MAPVAVWAALAVGLELWAAAHALPAQVAFTPYAPEPGSTCRLREYYDQTAQMCCSKCSPGQHAKVFCTKTSDTVCDSCEDSTYTQLWNWVPECLSCGSRCSSDQVETQACTREQNRICTCRPGWYCALSKQEGCRLCAPLRKCRPGFGVARPGTETSDVVCKPCAPGTFSNTTSSTDICRPHQICNVVAIPGNASMDAVCTSTSPTRSMAPGAVHLPQPVSTRSQHTQPTPEPSTAPSTSFLLPMGPSPPAEGSTGDFALPVGLIVGVTALGLLIIGVVNCVIMTQVKKKPLCLQREAKVPHLPADKARGTQGPEQQHLLITAPSSSSSSLESSASALDRRAPTRNQPQAPGVEASGAGEARASTGSSDSSPGGHGTQVNVTCIVNVCSSSDHSSQCSSQASSTMGDTDSSPSESPKDEQVPFSKEECAFRSQLETPETLLGSTEEKPLPLGVPDAGMKPS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T53033-Ab | Anti-TNR1B/ TNF-R2/ TNFRSF1B monoclonal antibody |
| Target Antigen | GM-Tg-g-T53033-Ag | TNF-R2/TNFRSF1B VLP (virus-like particle) |
| Cytokine | cks-Tg-g-GM-T53033 | tumor necrosis factor receptor superfamily, member 1B (TNFRSF1B) protein & antibody |
| ORF Viral Vector | pGMAP000424 | Human TNFRSF1B Adenovirus plasmid |
| ORF Viral Vector | vGMAP000424 | Human TNFRSF1B Adenovirus particle |
Target information
| Target ID | GM-T53033 |
| Target Name | TNFR2/TNFRSF1B/CD120b/TNF-R2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
7133 |
| Gene ID |
100055840 (Equus caballus), 101080392 (Felis catus), 156767 (Rattus norvegicus), 21938 (Mus musculus) 338033 (Bos taurus), 487437 (Canis lupus familiaris), 7133 (Homo sapiens), 715454 (Macaca mulatta) |
| Gene Symbols & Synonyms | TNFRSF1B,Tnfrsf1b,Tnfr2,p75,TNFBR,CD120b,TNF-R2,TNFR80,TNFRII,Tnfr-1,TNF-R75,TNF-R-II,TNF-alphaR2,TNFalpha-R2,TNF-RII/TNFRSF1B,TBPII,TNFR2,TNFR1B,p75TNFR |
| Target Alternative Names | CD120b,TBPII,TNF-R-II,TNF-R2,TNF-R75,TNF-RII/TNFRSF1B,TNF-alphaR2,TNFBR,TNFR-II),TNFR1B,TNFR2,TNFR80,TNFRII,TNFRSF1B,TNFalpha-R2,Tnfr-1,Tnfr2,Tnfrsf1b,Tumor necrosis factor receptor 2 (TNF-R2),Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis factor receptor type II (TNF-RII,p75,p75TNFR,p80 TNF-alpha receptor |
| Uniprot Accession |
P20333,P25119,Q80WY6
Additional SwissProt Accessions: Q80WY6,P25119,P20333 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, Cytokine Target |
| Disease | cancer, Ovary Cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, TNF signaling pathway, Adipocytokine signaling pathway |
| Gene Ensembl | ENSECAG00000012481, ENSMUSG00000028599, ENSBTAG00000024928, ENSCAFG00845001488, ENSG00000028137, ENSMMUG00000021447 |
| Target Classification | Cytokine Receptor, Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


